Navigation Links
China Nuvo Solar Target Acquisition SurgLine Reports on Marketing Progress
Date:8/24/2011

WEST PALM BEACH, Fla., Aug. 24, 2011 /PRNewswire/ -- China Nuvo Solar Energy, Inc. (OTCQB: CNUV) today announced that SurgLine's various sales channels are all reporting success that is exceeding expectations for the distribution of the Company's product lines. The Company's plan of action to sell through stocking distributors as well as channel distributors and potentially with medical co-ops and other third party outsourcing solutions is being received better than originally forecasted throughout the industry. SurgLine's product lines include trauma, orthopedic, spine and ENT medical and surgical products selling into hospitals and surgery centers.

Mr. Tom Toland, CEO of SurgLine was quoted as saying "As we speak to CFO's and CEO's of hospitals and surgery centers across the country, one common theme seems to emerge, they must cut costs without sacrificing the quality and healthcare at their facilities. SurgLine is able to meet both of these expectations by providing significant cost savings while maintaining their existing product quality."

Toland continued, SurgLine's corporate business proposition is simple, "More Value for Your Healthcare Dollar." Our team has the ability to source the same or similar surgical and medical products from the original manufacturer sources and bring them to the end user with significant savings. As we begin to source more surgical and medical products for our potential clients, we anticipate deeper penetration as a result of savings we can provide for the client base.  In some instances, SurgLine is negotiating for the exclusive distribution rights to market these products in the United States, which will provide SurgLine with an even greater value proposition to the end users in these important markets."

Richard Dutch, COO of SurgLine stated "We believe all of our sales partners will have continued success by transitioning more of their customers and taking advantage of our value-based pricing that does not compromise quality to the end user. The downward reimbursement pressures from insurance payers including the Federal Government and State Governments continues to erode operating margins for the hospital and surgical center operators. We believe we will continue to see substantial demand for our high quality, low cost products to be of significant value as a result of the quantifiable savings we can provide. One would expect that our orders will climb as we continue to introduce our value line of surgical products known as SURG to the marketplace."

About SurgLine, Inc.

SurgLine (www.surgline.com) sources and distributes high quality FDA approved medical and surgical products at discount prices, thereby reducing or eliminating  the historical brand premium paid by healthcare providers including acute care hospitals, surgery centers, surgical hospitals, self insured employers and insurance companies. SurgLine offers high quality medical and surgical supplies and products at substantial savings utilizing stocking distributors and institutional buyers by sourcing products globally without the historical brand premium and industry markup.

About China Nuvo Solar Energy

China Nuvo Solar Energy, Inc. is a development stage company that owns unique patent pending solar and photovoltaic related technology.  The Company is also seeking other business opportunities.

This press release may include forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements are based on the Company's current expectations as to future events. However, the forward-looking events and circumstances discussed in this press release might not occur, and actual results could differ materially from those anticipated or implied in the forward-looking statements.

For Further Information Contact:
Henry Fong, President
(561) 514-9042


'/>"/>
SOURCE China Nuvo Solar Energy, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. HUYA Bioscience Intl Announces Clinical Trial Milestones in China for Promising New Anti-Arrhythmic Compound; Data Supports Desirable Safety Profile
2. HUYA Bioscience Intl Announces World-Class Clinical Advisory Team for New Anti-Arrhythmic Compound Sourced From China
3. HUYA Bioscience Intl Announces First Pre-IND Outcome for a Development Stage Compound Sourced From China - HBI-8000, Promising New Cancer Compound
4. HUYA Bioscience Intl Announces Pre-IND Outcome for HBI-3000 - Promising Anti-Arrhythmia Compound Sourced From China
5. China Sky One Medical, Inc. Announces 26 New Drugs in Clinical Trials
6. RHEI Pharmaceuticals Announces the Initiation of the Final Clinical Study for Approval of Tibozole in China
7. Varian Medical Systems to Exhibit Cancer Treatment and X-ray Imaging Technologies at China Med Exhibition
8. China Sky One Medical, Inc. Achieves Significant Breakthrough in Research for Sudden Cardiac Death (SCD) Early Examination Kit
9. China Animal Welfare Law Under Review While 36,000 Dogs Culled
10. China-Biotics, Inc. Prices $69 Million Public Offering of Common Stock
11. Clifford Chance Advises Pfizer on Conditional Clearance in China of Its Merger with Wyeth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... NORRITON, Pa. , Feb. 8, 2016 /PRNewswire/ ... of November Research Group (NRG),s pharmacovigilance technology ... pharmacovigilance system-related consulting services and an Oracle Argus ... compliance services to Life Sciences companies. ... strengthens and expands HighPoint,s life sciences capabilities and ...
(Date:2/8/2016)... Switzerland and PALO ALTO, Calif. , Feb. ... and chemical manufacturing, and Kodiak Sciences Inc., a biopharmaceutical ... of retinal disease, announced today agreements for the clinical ... will manufacture material at multiple sites, including Slough (UK), ... --> --> Retinal diseases, such as ...
(Date:2/8/2016)... 2016  Avista Pharma Solutions ("Avista Pharma") announced today ... Financial Officer (CFO). Mr. Setzer is a finance and ... various roles within growing technology and life science companies. ... Executive Director of Finance at INC Research, a publicly ... . Previously, Mr. Setzer served as CFO of ...
Breaking Medicine Technology:
(Date:2/8/2016)... ... February 08, 2016 , ... Stephanie Hebert Insurance ... beginning of a new charity campaign. As part of their ongoing community involvement ... In the belief that children deserve a voice, and in the spirit of ...
(Date:2/8/2016)... ... February 08, 2016 , ... If you are feeling that ... you are not alone. According to the Center for Disease Control and Prevention (CDC), ... 2 diabetes and certain types of cancer, some of the leading causes of preventable ...
(Date:2/8/2016)... ... February 08, 2016 , ... Local insurance agency ... Venice, FL area, has initiated a fundraiser for a two year old little ... days after Christmas. To support this beautiful child who is facing life’s journey ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... frequently. While a significant number of women and men with eating disorders report ... itself, that best predicts the development of an eating disorder. , At ...
(Date:2/8/2016)... ... February 08, 2016 , ... The Association of Home ... and the Home Health and Hospice ICD-10 Transition Workgroup are working closely with ... guidance and clarifications, to address concerns over the use of 'A' as the ...
Breaking Medicine News(10 mins):